Rational approaches to the therapy of nosocomial infections caused by gram-positive microorganisms in cancer p
https://doi.org/10.21294/1814-4861-2017-16-5-12-17
Abstract
Nosocomial infections caused by gram-positive organisms, including Staphylococcus aureus and enterococci (Enterococcus faecium and Enterococcus faecalis) are steadily increasing in almost all clinics around the world. Cancer patients have a higher risk of hospital-acquired infections than non-cancer patients. Cancer patients are immunosuppressed due to increased use of broad-spectrum antibiotics and chemotherapy drugs, radiation therapy, surgery and use of steroids. This paper presents an analysis of resistance of gram-positive bacterial pathogens to antimicrobial agents to determine treatment strategy for cancer patients.
About the Authors
V. V. Aginova
N.N. Blokhin Russian Cancer Research Center (Moscow, Russia); Medical college
Russian Federation
Russian Federation
23, Kashirskoe shosse, Moscow-115478
6, Chuksin tupik, Moscow-127206
lecturer
N. V. Dmitrieva
N.N. Blokhin Russian Cancer Research Center
Russian Federation
Russian Federation
MD, DSc, Professor, Head of the Laboratory of Microbiological Diagnosis and Treatment of Infections in Cancer Patients
23, Kashirskoe shosse, Moscow-115478
SPIN-code: 8217-2448
Z. V. Grigorievskaya
N.N. Blokhin Russian Cancer Research Center
Russian Federation
Russian Federation
MD, DSc, Senior Researcher, Laboratory of Microbiological Diagnosis and Treatment of Infections in Cancer Patients
23, Kashirskoe shosse, Moscow-115478
SPIN-code: 4416-5191
I. N. Petukhova
N.N. Blokhin Russian Cancer Research Center
Russian Federation
Russian Federation
MD, DSc, Leading Researcher, Laboratory of Microbiological Diagnosis and Treatment of Infections in Cancer Patients
23, Kashirskoe shosse, Moscow-115478
SPIN-code: 1265-2875
N. S. Bagirova
N.N. Blokhin Russian Cancer Research Center
Russian Federation
Russian Federation
MD, DSc, Leading Researcher, Laboratory of Microbiological Diagnosis and Treatment of Infections in Cancer Patients
23, Kashirskoe shosse, Moscow-115478
SPIN-code: 3189-8188.
I. V. Tereshchenko
N.N. Blokhin Russian Cancer Research Center
Russian Federation
Russian Federation
Researcher, Laboratory of Microbiological Diagnosis and Treatment of Infections in Cancer Patients
23, Kashirskoe shosse, Moscow-115478
SPIN-code: 3185-9586.
I. А. Klyuchnikova
N.N. Blokhin Russian Cancer Research Center
Russian Federation
Russian Federation
physician-bacreriologist, Laboratory of Microbiological Diagnosis and Treatment of Infections in Cancer Patients
23, Kashirskoe shosse, Moscow-115478
SPIN-code: 6391-3737
References
1. Petukhova I.N, Dmitrieva N.V., Grigorievskaya Z.V., Bagirova N.S., Tereshchenko I.V., Dyakova S.A. Frequency of isolation of MRSA and other resistant gram-positive organisms in different departments of the oncology hospital. Clinical and laboratory diagnostics, 2016; 9: 125–126. [in Russian]
2. Dmitrieva N.V, Petukhova I.N., Grigorievskaya Z.V., Bagirova N.S., Tereshchenko I.V., Dyakova S.A., Sokolova E.N. Prevalence of nosocomial infection in cancer clinics. Clinical and laboratory diagnostics, 2016; 61 (9): 619–620. [in Russian]
3. Dmitrieva N.V, Petukhova I.N. Antimicrobial chemotherapy for hospital-acquired infections. Moscow, ABV press, 2015; 210–222. [in Russian]
4. Antimicrobial resistance surveillance in Europe 2015 [cited 01.11.2016]. URL: http://www.ecdc.europa.eu.
5. Rice L.B. Antimicrobial resistance in gram-positive bacteria. Am J Infect Control. 2006 Jun; 34 (5 Suppl 1): S11–9.
6. Antimicrobial Agent Use. Infectious Diseases Society of American (IDSA) [cited 01.11.2016]. URL: http://www.idsociety.org/Antimicrobial_Agents.
7. World Health Organization. WHO Global Strategy for Containment of Antimicrobial Resistance. Geneva, 2001; 90.
8. Loomba P.S., Taneja J., Mishra B. Methicillin and Vancomycin Resistant S. aureus in Hospitalized Patients. J Glob Infect Dis. 2010 Sep; 2 (3): 275–83. doi: 10.4103/0974-777X.68535.
9. Arias C.A., Murray B.E. The rise of the Enterococcus: beyond vancomicin resistance. Nat Rev Microbiol. 2012 Mar 16; 10 (4): 266–78. doi: 10.1038/nrmicro2761.
10. Krull M., Klare I., Ross B., Trenschel R., Beelen D.W., Todt D., Steinmann E., Buer J., Rath P.M., Steinmann J. Emergence of linezolidand vancomycin-resistant Enterococcus faecium in a department for hematologic stem cell transplantation. Antimicrob Resist Infect Control. 2016 Sep 22; 5: 31. doi: 10.1186/s13756-016-0131-6.
Review
For citations:
Aginova V.V., Dmitrieva N.V., Grigorievskaya Z.V., Petukhova I.N., Bagirova N.S., Tereshchenko I.V., Klyuchnikova I.А. Rational approaches to the therapy of nosocomial infections caused by gram-positive microorganisms in cancer p. Siberian journal of oncology. 2017;16(5):12-17. (In Russ.) https://doi.org/10.21294/1814-4861-2017-16-5-12-17
Views:
835
Email this article 
